PPP
PFE icon

Private Portfolio Partners’s Pfizer PFE Stock Holding History

Private Portfolio Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$1.3M Buy
48,873
+17,907
+58% +$486K 0.24% 72
2024
Q3 		$896K Buy
+30,966
New +$903K 0.17% 104
2024
Q2 		– Sell
-22,619
Closed -$628K – 209
2024
Q1 		$628K Buy
22,619
+5,207
+30% +$144K 0.13% 130
2023
Q4 		$501K Sell
17,412
-447
-3% -$13.5K 0.12% 143
2023
Q3 		$592K Buy
17,859
+239
+1% +$8.45K 0.15% 111
2023
Q2 		$646K Buy
17,620
+702
+4% +$27.3K 0.17% 100
2023
Q1 		$690K Sell
16,918
-457
-3% -$19.7K 0.19% 91
2022
Q4 		$890K Sell
17,375
-1,508
-8% -$72.3K 0.23% 84
2022
Q3 		$826K Sell
18,883
-691
-4% -$33.6K 0.24% 89
2022
Q2 		$1.03M Sell
19,574
-1,409
-7% -$71.8K 0.29% 76
2022
Q1 		$1.09M Buy
20,983
+1,613
+8% +$83.7K 0.27% 79
2021
Q4 		$1.14M Buy
19,370
+177
+0.9% +$8.77K 0.29% 75
2021
Q3 		$826K Buy
19,193
+4,622
+32% +$205K 0.24% 93
2021
Q2 		$571K Buy
14,571
+1,823
+14% +$70.9K 0.17% 119
2021
Q1 		$462K Sell
12,748
-122
-0.9% -$4.33K 0.15% 129
2020
Q4 		$474K Sell
12,870
-7,494
-37% -$275K 0.17% 119
2020
Q3 		$709K Buy
20,364
+11,566
+131% +$406K 0.29% 82
2020
Q2 		$273K Sell
8,798
-3,902
-31% -$133K 0.13% 150
2020
Q1 		$393K Buy
12,700
+735
+6% +$25K 0.21% 115
2019
Q4 		$445K Sell
11,965
-594
-5% -$21.2K 0.19% 115
2019
Q3 		$428K Sell
12,559
-10,305
-45% -$375K 0.2% 114
2019
Q2 		$939K Buy
22,864
+2,188
+11% +$86.9K 0.4% 71
2019
Q1 		$833K Buy
20,676
+705
+4% +$28.2K 0.44% 60
2018
Q4 		$827K Buy
+19,971
New +$829K 0.51% 57

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Private Portfolio Partners's PFE Position: Q4 2024 in Review

Private Portfolio Partners increased its Pfizer (PFE) stake by 58% in Q4 2024, buying an estimated $486K and bringing the position to 48,873 shares worth $1.3M. The position accounts for 0.24% of the portfolio, ranked #72.

Private Portfolio Partners first reported a position in PFE in Q4 2018 and has held it in 24 quarters since. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Private Portfolio Partners held 48,873 shares of Pfizer worth $1.3M as of Q4 2024.
  • Private Portfolio Partners bought 17,907 Pfizer shares in Q4 2024, an estimated $486K.
  • Pfizer made up 0.24% of Private Portfolio Partners's portfolio in Q4 2024, its #72 holding.
  • Private Portfolio Partners first reported a position in Pfizer in Q4 2018 and has held it in 24 quarters since.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Private Portfolio Partners's 13F filing for Q4 2024, filed 12 Feb 2025.